922 related articles for article (PubMed ID: 31106425)
1. Epithelial-mesenchymal transition in the formation of hypertrophic scars and keloids.
Yuan FL; Sun ZL; Feng Y; Liu SY; Du Y; Yu S; Yang ML; Lv GZ
J Cell Physiol; 2019 Dec; 234(12):21662-21669. PubMed ID: 31106425
[TBL] [Abstract][Full Text] [Related]
2. [Hyperplastic scars and keloids. Part I: basics and prevention].
Baisch A; Riedel F
HNO; 2006 Nov; 54(11):893-904; quiz 905. PubMed ID: 17041777
[TBL] [Abstract][Full Text] [Related]
3. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
Ogawa R; Akaishi S
Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
[TBL] [Abstract][Full Text] [Related]
4. Hypertrophic and keloid scars fail to progress from the CD34
Limandjaja GC; Belien JM; Scheper RJ; Niessen FB; Gibbs S
Br J Dermatol; 2020 Apr; 182(4):974-986. PubMed ID: 31206605
[TBL] [Abstract][Full Text] [Related]
5. Keloids and hypertrophic scars: are they two different sides of the same coin?
Köse O; Waseem A
Dermatol Surg; 2008 Mar; 34(3):336-46. PubMed ID: 18177398
[TBL] [Abstract][Full Text] [Related]
6. [Research advances on the role and mechanism of inflammatory response in the formation of hypertrophic scars and keloids].
Wang HT; Han JT; Hu DH
Zhonghua Shao Shang Za Zhi; 2021 May; 37(5):490-494. PubMed ID: 34044530
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.
Gauglitz GG; Korting HC; Pavicic T; Ruzicka T; Jeschke MG
Mol Med; 2011; 17(1-2):113-25. PubMed ID: 20927486
[TBL] [Abstract][Full Text] [Related]
8. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
9. Keloids are transcriptionally distinct from normal and hypertrophic scars.
Walter AS; Stocks M; Akova E; Gauglitz G; Hartmann D; Aszodi A; Böcker W; Saller MM; Volkmer E
Eur J Dermatol; 2023 Dec; 33(6):604-611. PubMed ID: 38465540
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic scars and keloids.
Haverstock BD
Clin Podiatr Med Surg; 2001 Jan; 18(1):147-59. PubMed ID: 11344975
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
12. Keloids: current concepts of pathogenesis (review).
Bran GM; Goessler UR; Hormann K; Riedel F; Sadick H
Int J Mol Med; 2009 Sep; 24(3):283-93. PubMed ID: 19639219
[TBL] [Abstract][Full Text] [Related]
13. Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.
Lee HJ; Jang YJ
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498630
[TBL] [Abstract][Full Text] [Related]
14. Advances in scar management: prevention and management of hypertrophic scars and keloids.
Del Toro D; Dedhia R; Tollefson TT
Curr Opin Otolaryngol Head Neck Surg; 2016 Aug; 24(4):322-9. PubMed ID: 27163611
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Evaluation of Leptin Expression in Wound Healing: A Clue to Exuberant Scar Formation.
Seleit I; Bakry OA; Samaka RM; Tawfik AS
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):296-306. PubMed ID: 26258753
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophic scars and keloids: Overview of the evidence and practical guide for differentiating between these abnormal scars.
Limandjaja GC; Niessen FB; Scheper RJ; Gibbs S
Exp Dermatol; 2021 Jan; 30(1):146-161. PubMed ID: 32479693
[TBL] [Abstract][Full Text] [Related]
17. The effect of the anti-allergic agent avil on abnormal scar fibroblasts.
Venugopal J; Ramakrishnan M; Habibullah CM; Babu M
Burns; 1999 May; 25(3):223-8. PubMed ID: 10323606
[TBL] [Abstract][Full Text] [Related]
18. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.
Amadeu T; Braune A; Mandarim-de-Lacerda C; Porto LC; Desmoulière A; Costa A
Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263
[TBL] [Abstract][Full Text] [Related]
19. Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed flat scars, and dermatofibroma.
Akasaka Y; Fujita K; Ishikawa Y; Asuwa N; Inuzuka K; Ishihara M; Ito M; Masuda T; Akishima Y; Zhang L; Ito K; Ishii T
Wound Repair Regen; 2001; 9(6):501-6. PubMed ID: 11896992
[TBL] [Abstract][Full Text] [Related]
20. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids.
Amadeu TP; Braune AS; Porto LC; Desmoulière A; Costa AM
Wound Repair Regen; 2004; 12(2):169-74. PubMed ID: 15086768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
